Search Results 111-120 of 19569 for alzheimers
... Alzheimer's symptoms. “This study has furthered our understanding of the gene that is the strongest genetic risk factor known for Alzheimer's disease,” says Dr.
Mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been identified as risk factors for late-onset Alzheimer's disease.
Learn more how new discoveries at Mayo Clinic reshape Alzheimer's disease detection in the latest episode of Tomorrow's Cure.
MCI raises the risk of developing dementia caused by Alzheimer's disease or other brain conditions. But for some people with mild cognitive impairment, symptoms ...
Families living with Alzheimer's disease woke to devastating newspaper headlines recently: Another highly touted drug failed in clinical trials.
It's estimated that 5 million Americans age 65 and older may have Alzheimer's disease. And with an aging population on the rise, that number is expected to ...
Thus, it is not surprising that those diagnosed with Lewy body dementia have symptoms associated with Alzheimer disease, such as memory loss and naming ...
Wandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen in the early ...
Colleagues and other Alzheimer's researchers say his team's contributions to Alzheimer's research rank among the most significant in the field. “We are very ...
The most common gene associated with late-onset Alzheimer's disease is called apolipoprotein E (APOE). APOE has three common forms: APOE e2 — the least common — ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.